The global renal cancer drug market is projected to grow at a significant CAGR during the forecast period. Renal cancer occurs in the lining of the proximal convoluted tubule of the kidney. Several factors leading to renal cancer include obesity, smoking, high blood pressure, Von Hippel-Lindau (VHL) syndrome, and long-term dialysis, among others. Whereas, symptoms include blood in the urine, mass or lump in the abdomen, weight loss, and lethargy among others. The primary factors that drive the growth of the market include increased incidences of renal cancer, rising older population, and the advent of advanced diagnostic techniques and drugs for the detection and treatment. However, increased preferences of peoples towards the generic drugs owing to the higher prices of the branded drug are the primary factor hindering the growth of the market.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/renal-cancer-drugs-market
Besides, key players' contributions along with the ongoing clinical trials of several drugs are likely to create scope for the market growth. For instance, in January 2020, Aravive, Inc., a clinical-stage biopharmaceutical company, announced that the US FDA has cleared the company’s Investigational New Drug (IND) application for investigation of the company’s lead candidate, AVB-500, for the treatment of clear cell renal cell carcinoma (ccRCC). Such clinical trials for the development of novel drugs are estimated to flourish the market growth during the forecast period.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/renal-cancer-drugs-market
Market Segmentation
Global Renal Cancer Drugs Market by Cancer Type
• Renal Cancer Carcinoma
• Clear Cell Renal Cell Carcinoma
• Non-Clear Renal Cell Carcinoma
• Others
Global Renal Cancer Drugs Market by Drug Class
• Angiogenesis Inhibitors
• Monoclonal Antibodies
• mTOR Inhibitors
• Cytokine Immunotherapy (IL-2)
Global Renal Cancer Drugs Market by Therapeutic Class
• Targeted Therapy
• Immunotherapy
• Chemotherapy
Regional Analysis
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World
Company Profiles
• Active Biotech AB
• Amgen Inc.
• Aravive, Inc.
• Argos Therapeutics Inc.
• Bayer AG
• Bristol Myers Squibb Co.
• Cipla Ltd.
• Eisai Co., Ltd.
• Exelixis, Inc.
• Genentech, Inc.
• GlaxoSmithKline Plc
• Myriad Genetics Inc.
• NanoString Technologies Inc.
• NeoGenomics Laboratories Inc.
• Novartis International AG
• Pfizer, Inc
• Prometheus Laboratories Inc.
• Rosetta Genomics Ltd.
• Sysmex Corp.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/renal-cancer-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404